Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.

Meng H, Li W, Boardman LA, Wang L.

BMC Cancer. 2018 Apr 16;18(1):433. doi: 10.1186/s12885-018-4337-2.

2.

Colonoscopy surveillance for high risk polyps does not always prevent colorectal cancer.

Mouchli MA, Ouk L, Scheitel MR, Chaudhry AP, Felmlee-Devine D, Grill DE, Rashtak S, Wang P, Wang J, Chaudhry R, Smyrk TC, Oberg AL, Druliner BR, Boardman LA.

World J Gastroenterol. 2018 Feb 28;24(8):905-916. doi: 10.3748/wjg.v24.i8.905.

3.

Inferring modes of evolution from colorectal cancer with residual polyp of origin.

Kim M, Druliner BR, Vasmatzis N, Bae T, Chia N, Abyzov A, Boardman LA.

Oncotarget. 2017 Dec 26;9(6):6780-6792. doi: 10.18632/oncotarget.23687. eCollection 2018 Jan 23.

4.

Molecular characterization of colorectal adenomas with and without malignancy reveals distinguishing genome, transcriptome and methylome alterations.

Druliner BR, Wang P, Bae T, Baheti S, Slettedahl S, Mahoney D, Vasmatzis N, Xu H, Kim M, Bockol M, O'Brien D, Grill D, Warner N, Munoz-Gomez M, Kossick K, Johnson R, Mouchli M, Felmlee-Devine D, Washechek-Aletto J, Smyrk T, Oberg A, Wang J, Chia N, Abyzov A, Ahlquist D, Boardman LA.

Sci Rep. 2018 Feb 16;8(1):3161. doi: 10.1038/s41598-018-21525-4.

5.

A mutational comparison of adult and adolescent and young adult (AYA) colon cancer.

Tricoli JV, Boardman LA, Patidar R, Sindiri S, Jang JS, Walsh WD, McGregor PM 3rd, Camalier CE, Mehaffey MG, Furman WL, Bahrami A, Williams PM, Lih CJ, Conley BA, Khan J.

Cancer. 2018 Mar 1;124(5):1070-1082. doi: 10.1002/cncr.31136. Epub 2017 Nov 30.

PMID:
29194591
6.

Draft Genome Sequence of Methanobrevibacter smithii Isolate WWM1085, Obtained from a Human Stool Sample.

Jennings ME, Chia N, Boardman LA, Metcalf WW.

Genome Announc. 2017 Sep 28;5(39). pii: e01055-17. doi: 10.1128/genomeA.01055-17.

7.

Moderate-to-severe obstructive sleep apnea is associated with telomere lengthening.

Polonis K, Somers VK, Becari C, Covassin N, Schulte PJ, Druliner BR, Johnson RA, Narkiewicz K, Boardman LA, Singh P.

Am J Physiol Heart Circ Physiol. 2017 Nov 1;313(5):H1022-H1030. doi: 10.1152/ajpheart.00197.2017. Epub 2017 Aug 19.

PMID:
28822964
8.

Novel Approach to Fecal Occult Blood Testing by Assay of Erythrocyte-Specific microRNA Markers.

Wu CW, Cao X, Berger CK, Foote PH, Mahoney DW, Simonson JA, Anderson BW, Yab TC, Taylor WR, Boardman LA, Kisiel JB, Ahlquist DA.

Dig Dis Sci. 2017 Aug;62(8):1985-1994. doi: 10.1007/s10620-017-4627-6. Epub 2017 Jun 28.

PMID:
28660489
9.

Telomere Length and Pancreatic Cancer Risk-Reply.

Antwi SO, Boardman LA, Petersen GM.

Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1158-1159. doi: 10.1158/1055-9965.EPI-17-0307. Epub 2017 Jun 20. No abstract available.

PMID:
28634187
10.

Individualized Medicine in Gastroenterology and Hepatology.

Stephens MC, Boardman LA, Lazaridis KN.

Mayo Clin Proc. 2017 May;92(5):810-825. doi: 10.1016/j.mayocp.2017.03.002. Review.

PMID:
28473040
11.

Time Lapse to Colorectal Cancer: Telomere Dynamics Define the Malignant Potential of Polyps.

Druliner BR, Ruan X, Johnson R, Grill D, O'Brien D, Lai TP, Rashtak S, Felmlee-Devine D, Washechek-Aletto J, Malykh A, Smyrk T, Oberg A, Liu H, Shay JW, Ahlquist DA, Boardman LA.

Clin Transl Gastroenterol. 2017 Apr 13;8(4):e88. doi: 10.1038/ctg.2017.16. No abstract available.

12.

Peripheral Neutrophil to Lymphocyte Ratio Improves Prognostication in Colon Cancer.

Rashtak S, Ruan X, Druliner BR, Liu H, Therneau T, Mouchli M, Boardman LA.

Clin Colorectal Cancer. 2017 Jun;16(2):115-123.e3. doi: 10.1016/j.clcc.2017.01.008. Epub 2017 Jan 25.

PMID:
28365393
13.

Genetically Predicted Telomere Length is not Associated with Pancreatic Cancer Risk.

Antwi SO, Bamlet WR, Broderick BT, Chaffee KG, Oberg A, Jatoi A, Boardman LA, Petersen GM.

Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):971-974. doi: 10.1158/1055-9965.EPI-17-0100. Epub 2017 Mar 6.

PMID:
28264873
14.

Shifts in the Fecal Microbiota Associated with Adenomatous Polyps.

Hale VL, Chen J, Johnson S, Harrington SC, Yab TC, Smyrk TC, Nelson H, Boardman LA, Druliner BR, Levin TR, Rex DK, Ahnen DJ, Lance P, Ahlquist DA, Chia N.

Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):85-94. doi: 10.1158/1055-9965.EPI-16-0337. Epub 2016 Sep 26.

15.

Time Lapse to Colorectal Cancer: Telomere Dynamics Define the Malignant Potential of Polyps.

Druliner BR, Ruan X, Johnson R, Grill D, O'Brien D, Lai TP, Rashtak S, Felmlee-Devine D, Washechek-Aletto J, Malykh A, Smyrk T, Oberg A, Liu H, Shay JW, Ahlquist DA, Boardman LA.

Clin Transl Gastroenterol. 2016 Sep 1;7(9):e188. doi: 10.1038/ctg.2016.48.

16.

Colorectal Cancer with Residual Polyp of Origin: A Model of Malignant Transformation.

Druliner BR, Rashtak S, Ruan X, Bae T, Vasmatzis N, O'Brien D, Johnson R, Felmlee-Devine D, Washechek-Aletto J, Basu N, Liu H, Smyrk T, Abyzov A, Boardman LA.

Transl Oncol. 2016 Aug;9(4):280-6. doi: 10.1016/j.tranon.2016.06.002. Epub 2016 Jul 9.

17.

Pouchitis Is a Common Complication in Patients With Familial Adenomatous Polyposis Following Ileal Pouch-Anal Anastomosis.

Quinn KP, Lightner AL, Pendegraft RS, Enders FT, Boardman LA, Raffals LE.

Clin Gastroenterol Hepatol. 2016 Sep;14(9):1296-301. doi: 10.1016/j.cgh.2016.04.010. Epub 2016 Apr 13.

PMID:
27085760
18.

Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma.

Tricoli JV, Blair DG, Anders CK, Bleyer WA, Boardman LA, Khan J, Kummar S, Hayes-Lattin B, Hunger SP, Merchant M, Seibel NL, Thurin M, Willman CL.

Cancer. 2016 Apr 1;122(7):1017-28. doi: 10.1002/cncr.29871. Epub 2016 Feb 5. Review.

19.

A common variant in MTHFR influences response to chemoradiotherapy and recurrence of rectal cancer.

Nikas JB, Lee JT, Maring ED, Washechek-Aletto J, Felmlee-Devine D, Johnson RA, Smyrk TC, Tawadros PS, Boardman LA, Steer CJ.

Am J Cancer Res. 2015 Sep 15;5(10):3231-40. eCollection 2015.

20.

DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53.

Alam SK, Yadav VK, Bajaj S, Datta A, Dutta SK, Bhattacharyya M, Bhattacharya S, Debnath S, Roy S, Boardman LA, Smyrk TC, Molina JR, Chakrabarti S, Chowdhury S, Mukhopadhyay D, Roychoudhury S.

Cell Death Differ. 2016 Apr;23(4):707-22. doi: 10.1038/cdd.2015.133. Epub 2015 Oct 23.

21.

What Is New in Human Papillomavirus-Related Lower Anogenital Tract Disease Prevention and Screening?: Best Articles From the Past Year.

Boardman LA.

Obstet Gynecol. 2015 Oct;126(4):892-4. doi: 10.1097/AOG.0000000000001081.

PMID:
26348170
22.

Screening for Anal Cancer in Women.

Moscicki AB, Darragh TM, Berry-Lawhorn JM, Roberts JM, Khan MJ, Boardman LA, Chiao E, Einstein MH, Goldstone SE, Jay N, Likes WM, Stier EA, Welton ML, Wiley DJ, Palefsky JM.

J Low Genit Tract Dis. 2015 Jul;19(3 Suppl 1):S27-42. doi: 10.1097/LGT.0000000000000117. Review.

23.

Aspirin Prevents Colorectal Cancer by Normalizing EGFR Expression.

Li H, Zhu F, Boardman LA, Wang L, Oi N, Liu K, Li X, Fu Y, Limburg PJ, Bode AM, Dong Z.

EBioMedicine. 2015 May 1;2(5):447-455.

24.

New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice.

Kisiel JB, Raimondo M, Taylor WR, Yab TC, Mahoney DW, Sun Z, Middha S, Baheti S, Zou H, Smyrk TC, Boardman LA, Petersen GM, Ahlquist DA.

Clin Cancer Res. 2015 Oct 1;21(19):4473-81. doi: 10.1158/1078-0432.CCR-14-2469. Epub 2015 May 28.

25.

Circulating Prostaglandin Biosynthesis in Colorectal Cancer and Potential Clinical Significance.

Li H, Liu K, Boardman LA, Zhao Y, Wang L, Sheng Y, Oi N, Limburg PJ, Bode AM, Dong Z.

EBioMedicine. 2015 Feb 1;2(2):165-171.

26.

Short and long telomeres increase risk of amnestic mild cognitive impairment.

Roberts RO, Boardman LA, Cha RH, Pankratz VS, Johnson RA, Druliner BR, Christianson TJ, Roberts LR, Petersen RC.

Mech Ageing Dev. 2014 Nov-Dec;141-142:64-9. doi: 10.1016/j.mad.2014.10.002. Epub 2014 Oct 22.

27.

HDAC8 and STAT3 repress BMF gene activity in colon cancer cells.

Kang Y, Nian H, Rajendran P, Kim E, Dashwood WM, Pinto JT, Boardman LA, Thibodeau SN, Limburg PJ, Löhr CV, Bisson WH, Williams DE, Ho E, Dashwood RH.

Cell Death Dis. 2014 Oct 16;5:e1476. doi: 10.1038/cddis.2014.422.

28.

Toward a molecular classification of colorectal cancer: the role of telomere length.

Baichoo E, Boardman LA.

Front Oncol. 2014 Jun 18;4:158. doi: 10.3389/fonc.2014.00158. eCollection 2014. Review.

29.

Telomere length varies by DNA extraction method: implications for epidemiologic research--response.

Boardman LA, Skinner HG, Litzelman K.

Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):1131. doi: 10.1158/1055-9965.EPI-14-0234. Epub 2014 May 5. No abstract available.

30.

Clinical recommendation: pediatric lichen sclerosus.

Bercaw-Pratt JL, Boardman LA, Simms-Cendan JS; North American Society for Pediatric and Adolescent Gynecology.

J Pediatr Adolesc Gynecol. 2014 Apr;27(2):111-6. doi: 10.1016/j.jpag.2013.11.004.

PMID:
24602304
31.

The association of telomere length with colorectal cancer differs by the age of cancer onset.

Boardman LA, Litzelman K, Seo S, Johnson RA, Vanderboom RJ, Kimmel GW, Cunningham JM, Gangnon RE, Engelman CD, Riegert-Johnson DL, Potter J, Haile R, Buchanan D, Jenkins MA, Rider DN, Thibodeau SN, Petersen GM, Skinner HG.

Clin Transl Gastroenterol. 2014 Mar 6;5:e52. doi: 10.1038/ctg.2014.3.

32.

Gastric adenomas in familial adenomatous polyposis are common, but subtle, and have a benign course.

Ngamruengphong S, Boardman LA, Heigh RI, Krishna M, Roberts ME, Riegert-Johnson DL.

Hered Cancer Clin Pract. 2014 Feb 24;12(1):4. doi: 10.1186/1897-4287-12-4.

33.

What is new in hormonal management and menopause?: Best articles from the past year.

Boardman LA.

Obstet Gynecol. 2014 Mar;123(3):661-3. doi: 10.1097/AOG.0000000000000149.

PMID:
24499766
34.

Prospective evaluation of adverse events following lower gastrointestinal tract EUS FNA.

Levy MJ, Abu Dayyeh BK, Fujii LL, Boardman LA, Clain JE, Iyer PG, Rajan E, Topazian MD, Wang KK, Wiersema MJ, Gleeson FC.

Am J Gastroenterol. 2014 May;109(5):676-85. doi: 10.1038/ajg.2013.479. Epub 2014 Jan 28.

PMID:
24469614
35.

Endoscopically identified well-differentiated rectal carcinoid tumors: impact of tumor size on the natural history and outcomes.

Gleeson FC, Levy MJ, Dozois EJ, Larson DW, Wong Kee Song LM, Boardman LA.

Gastrointest Endosc. 2014 Jul;80(1):144-51. doi: 10.1016/j.gie.2013.11.031. Epub 2014 Jan 23.

PMID:
24462168
36.

Correlation of chromosomal instability, telomere length and telomere maintenance in microsatellite stable rectal cancer: a molecular subclass of rectal cancer.

Boardman LA, Johnson RA, Viker KB, Hafner KA, Jenkins RB, Riegert-Johnson DL, Smyrk TC, Litzelman K, Seo S, Gangnon RE, Engelman CD, Rider DN, Vanderboom RJ, Thibodeau SN, Petersen GM, Skinner HG.

PLoS One. 2013 Nov 21;8(11):e80015. doi: 10.1371/journal.pone.0080015. eCollection 2013.

37.

Telomeres and telomere dynamics: relevance to cancers of the GI tract.

Basu N, Skinner HG, Litzelman K, Vanderboom R, Baichoo E, Boardman LA.

Expert Rev Gastroenterol Hepatol. 2013 Nov;7(8):733-48. doi: 10.1586/17474124.2013.848790. Review.

38.

Telomere length varies by DNA extraction method: implications for epidemiologic research.

Cunningham JM, Johnson RA, Litzelman K, Skinner HG, Seo S, Engelman CD, Vanderboom RJ, Kimmel GW, Gangnon RE, Riegert-Johnson DL, Baron JA, Potter JD, Haile R, Buchanan DD, Jenkins MA, Rider DN, Thibodeau SN, Petersen GM, Boardman LA.

Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):2047-54. doi: 10.1158/1055-9965.EPI-13-0409. Epub 2013 Sep 9.

39.

Enhanced primer selection and synthetic amplicon templates optimize high-resolution melting analysis of single-nucleotide polymorphisms in a large population.

Bruzzone CM, Tawadros PS, Boardman LA, Steer CJ.

Genet Test Mol Biomarkers. 2013 Sep;17(9):675-80. doi: 10.1089/gtmb.2013.0113. Epub 2013 Jun 22.

40.

Screening adolescents and young women.

Boardman LA, Robison K.

Obstet Gynecol Clin North Am. 2013 Jun;40(2):257-68. doi: 10.1016/j.ogc.2013.02.007. Epub 2013 Apr 17.

41.

Barriers to completion of desired postpartum sterilization.

Boardman LA, DeSimone M, Allen RH.

R I Med J (2013). 2013 Feb 1;96(2):32-4.

PMID:
23641425
42.

Telomere length and pancreatic cancer: a case-control study.

Skinner HG, Gangnon RE, Litzelman K, Johnson RA, Chari ST, Petersen GM, Boardman LA.

Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):2095-100. doi: 10.1158/1055-9965.EPI-12-0671. Epub 2012 Oct 23.

43.

Shorter peripheral blood telomeres are a potential biomarker for patients with advanced colorectal adenomas.

Riegert-Johnson DL, Boardman LA, Crook JE, Thomas CS, Johnson RA, Roberts ME.

Int J Biol Markers. 2012 Dec 27;27(4):e375-80. doi: 10.5301/JBM.2012.9347.

44.

Cronkhite-Canada syndrome: an acquired condition of gastrointestinal polyposis and dermatologic abnormalities.

Sweetser S, Boardman LA.

Gastroenterol Hepatol (N Y). 2012 Mar;8(3):201-3. No abstract available.

45.

Generation and external validation of a tumor-derived 5-gene prognostic signature for recurrence of lymph node-negative, invasive colorectal carcinoma.

Lenehan PF, Boardman LA, Riegert-Johnson D, De Petris G, Fry DW, Ohrnberger J, Heyman ER, Gerard B, Almal AA, Worzel WP.

Cancer. 2012 Nov 1;118(21):5234-44. doi: 10.1002/cncr.27628. Epub 2012 May 17.

46.

Local recurrence detection following transanal excision facilitated by EUS-FNA.

Gleeson FC, Larson DW, Dozois EJ, Boardman LA, Clain JE, Rajan E, Topazian MD, Wang KK, Levy MJ.

Hepatogastroenterology. 2012 Jun;59(116):1102-7. doi: 10.5754/hge11898.

PMID:
22281976
47.

The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia.

Ahlquist DA, Taylor WR, Mahoney DW, Zou H, Domanico M, Thibodeau SN, Boardman LA, Berger BM, Lidgard GP.

Clin Gastroenterol Hepatol. 2012 Mar;10(3):272-7.e1. doi: 10.1016/j.cgh.2011.10.008. Epub 2011 Oct 20.

48.

Clinicopathologic features and treatment outcomes in Cronkhite-Canada syndrome: support for autoimmunity.

Sweetser S, Ahlquist DA, Osborn NK, Sanderson SO, Smyrk TC, Chari ST, Boardman LA.

Dig Dis Sci. 2012 Feb;57(2):496-502. doi: 10.1007/s10620-011-1874-9. Epub 2011 Sep 1.

PMID:
21881972
49.

A rare cause of obscure gastrointestinal bleeding. Diagnosis: Sporadic Peutz-Jeghers type jejunal polyp causing obsucre GI bleeding.

Sweetser S, Sugumar A, Boardman LA.

Gastroenterology. 2011 Oct;141(4):1159, 1533. doi: 10.1053/j.gastro.2009.10.062. Epub 2011 Aug 19. No abstract available.

PMID:
21856304
50.

Lynch syndrome-associated extracolonic tumors are rare in two extended families with the same EPCAM deletion.

Lynch HT, Riegert-Johnson DL, Snyder C, Lynch JF, Hagenkord J, Boland CR, Rhees J, Thibodeau SN, Boardman LA, Davies J, Kuiper RP, Hoogerbrugge N, Ligtenberg MJ.

Am J Gastroenterol. 2011 Oct;106(10):1829-36. doi: 10.1038/ajg.2011.203. Epub 2011 Jul 19.

Supplemental Content

Loading ...
Support Center